Conrad Wai - 14 Mar 2026 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
CEO, Counterpart Health
Signature
/s/ Peter J. Rivas as attorney-in-fact for Conrad Wai
Issuer symbol
CLOV
Transactions as of
14 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 16:27:13 UTC
Previous filing
20 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wai Conrad CEO, Counterpart Health C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON /s/ Peter J. Rivas as attorney-in-fact for Conrad Wai 17 Mar 2026 0001971702

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Tax liability -100,195 -9.8% $1.98* 925,611 14 Mar 2026 Direct F1
holding CLOV Class A Common Stock 1,610,482 14 Mar 2026 By Trust. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2026, of the final 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022.
F2 Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.